Introduction: Giant cell tumor (GCT) is a distinctive lesion characterized by the proliferation of multinucleate giant cells in a stroma of mononuclear cells; it is generally seen in skeletally mature individuals. GCT is usually found in the long bones around the knee or in the distal radius but distal end of tibia, proximal humerus, vertebrae of young adults are unusual location. We report a case of GCT of the distal end of tibia, with a secondary aneurysmal bone cyst, in a 26-year-old female. Based on our review of the medical literature, it appears that the occurrence of a GCT along with a secondary aneurysmal bone cyst (ABC) in distal end of tibia is less typical with challenging task for full tumor resection and restoration of ankle function to normal.
Case Summary: 26 year old female presented with pain&swelling over left ankle since last six month. Biopsy was suggestive of GCT with ABC of lower third tibia. We managed this case with intralesional curettage using phenol and burr and bone graft harvested from left iliac crest for reconstruction of defect along with kwire fixation to achieve optimum anatomical restoration.
Conclusion: In cases of GCT, the management depends upon the various factors such as site, age, involvement of the bone, extent of bone involvement and whether there is articular involvement or not. Here Intra-articular GCT is managed with extended intralesional curettage with phenol. Bone graft plays a role of agent for reconstruction of the defect and kwire for anatomical reduction.
Amanatullah DF, Clark TR, Lopez MJ, Borys D, Tamurian RM. Giant cell tumor of bone. Orthopedics. 2014; 37(2): 112-120.
Knochentumoren A. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. JBJS. 2008; 90(5): 1060-1067.
Balke M, Campanacci L, Gebert C, Picci P, Gibbons M, Taylor R, et al. Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone. BMC cancer. 2010; 10(1): 1-8.
Boriani S, Bandiera S, Casadei R, Boriani L, Donthineni R, Gasbarrini A, Giant cell tumor of the mobile spine: a review of 49 cases. Spine. 2012; 37(1): E37-E45.
Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clinical Cancer Research. 2012; 18(16): 4415-4424.
Chan CM, Adler Z, Reith JD, Gibbs Jr CP. Risk factors for pulmonary metastases from giant cell tumor of bone. JBJS. 2015; 97(5): 420-428.
Gao ZH, Yin JQ, Xie XB, Zou CY, Huang G, Shen JN. Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement. BMC Musculoskeletal Disorders. 2014; 15(1): 1-8.
Gortzak Y, Kandel R, Deheshi B, Werier J, Turcotte RE, Ferguson PC, et al. The efficacy of chemical adjuvants on giant-cell tumour of bone: an in vitro study. The Journal of Bone and Joint Surgery. British Volume. 2010; 92(10): 1475-1479.
Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clinical Orthopaedics and Related Research®. 2011; 469(2): 591-599.
Park SY, Lee MH, Lee JS, Song JS, Chung HW. Ossified soft tissue recurrence of giant cell tumor of the bone: four case reports with follow-up radiographs, CT, ultrasound, and MR images. Skeletal Radiology. 2014; 43(10): 1457-1463.
Siddiqui MA, Seng C, Tan MH. Risk factors for recurrence of giant cell tumours of bone. Journal of Orthopaedic Surgery. 2014; 22(1): 108-110.
Skubitz KM. Giant cell tumor of bone: current treatment options. Current Treatment Options in Oncology. 2014; 15(3): 507-518.
This work is licensed under a Creative Commons Attribution 4.0 International License.